Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership1,711 shares
Latest Disclosed Value $ 100,642
Parallel Advisors, LLC ownership in TECH / Bio-Techne Corporation

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 1,711 shares of Bio-Techne Corporation (US:TECH) valued at $100,624 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 1,618 shares of Bio-Techne Corporation. This represents a change in shares of 5.75% during the quarter. The current value of the position is $87,004 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (TECH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TECH / Bio-Techne Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F BIO-TECHNE CORP COM Stock 09073M104 1,711 93 5.75 101 11.11 0.0018
2025-11-13 2025-09-30 13F BIO-TECHNE CORP COM Stock 09073M104 1,618 115 7.65 90 16.88 0.0016
2025-07-08 2025-06-30 13F BIO-TECHNE CORP COM Stock 09073M104 1,503 -594 -28.33 77 -36.89 0.0015
2025-04-08 2025-03-31 13F BIO-TECHNE CORP COM Stock 09073M104 2,097 -667 -24.13 123 -38.69 0.0028
2025-02-10 2024-12-31 13F BIO-TECHNE CORP COM Stock 09073M104 2,764 435 18.68 199 6.99 0.0045
2024-11-13 2024-09-30 13F BIO-TECHNE CORP COM Stock 09073M104 2,329 -329 -12.38 186 -2.11 0.0044
2024-08-08 2024-06-30 13F BIO-TECHNE CORP COM Stock 09073M104 2,658 46 1.76 190 3.83 0.0049
2024-05-06 2024-03-31 13F BIO-TECHNE CORP COM Stock 09073M104 2,612 465 21.66 184 10.91 0.0050
2024-02-12 2023-12-31 13F BIO-TECHNE CORP COM Stock 09073M104 2,147 304 16.49 166 32.00 0.0049
2024-05-20 2023-09-30 13F/A-1 BIO-TECHNE CORP COM Stock 09073M104 1,843 -272 -12.86 125 -27.33 0.0042
2023-11-14 2023-09-30 13F BIO-TECHNE CORP COM Stock 09073M104 1,843 -272 125 0.0042
2024-05-20 2023-06-30 13F/A-1 BIO-TECHNE CORP COM Stock 09073M104 2,115 237 12.62 173 23.74 0.0056
2023-08-04 2023-06-30 13F BIO-TECHNE CORP COM Stock 09073M104 2,115 237 173 0.0056
2024-05-20 2023-03-31 13F/A-1 BIO-TECHNE CORP COM Stock 09073M104 1,878 -868 -31.61 139 -38.77 0.0047
2023-04-25 2023-03-31 13F BIO-TECHNE CORP COM Stock 09073M104 1,878 -868 139 0.0047
2023-02-06 2022-12-31 13F BIO-TECHNE CORP COM Stock 09073M104 2,746 2,092 319.88 228 22.04 0.0099
2022-11-10 2022-09-30 13F BIO-TECHNE CORP COM Stock 09073M104 654 -23 -3.40 186 -20.85 0.0086
2022-08-01 2022-06-30 13F BIO-TECHNE CORP COM Stock 09073M104 677 -107 -13.65 235 -32.28 0.0108
2022-04-28 2022-03-31 13F BIO-TECHNE CORP COM Stock 09073M104 784 -28 -3.45 347 -17.38 0.0138
2022-01-20 2021-12-31 13F BIO-TECHNE CORP COM Stock 09073M104 812 110 15.67 420 23.53 0.0156
2021-11-02 2021-09-30 13F/A-1 BIO-TECHNE CORP COM Stock 09073M104 702 91 14.89 340 23.64 0.0137
2021-08-06 2021-06-30 13F BIO-TECHNE CORP COM Stock 09073M104 611 43 7.57 275 26.73 0.0116
2021-04-23 2021-03-31 13F BIO-TECHNE CORP COM Stock 09073M104 568 58 11.37 217 33.95 0.0102
2021-02-02 2020-12-31 13F BIO-TECHNE CORP COM Stock 09073M104 510 82 19.16 162 52.83 0.0088
2020-10-27 2020-09-30 13F BIO-TECHNE CORP COM Stock 09073M104 428 43 11.17 106 4.95 0.0066
2020-07-16 2020-06-30 13F BIO-TECHNE CORP COM Stock 09073M104 385 108 38.99 101 94.23 0.0066
2020-04-27 2020-03-31 13F BIO-TECHNE CORP COM Stock 09073M104 277 29 11.69 52 -3.70 0.0042
2020-01-30 2019-12-31 13F BIO TECHNE CORP COM Stock 09073M104 248 135 119.47 54 145.45 0.0041
2019-11-01 2019-09-30 13F BIO TECHNE CORP COM Stock 09073M104 113 -11 -8.87 22 -15.38 0.0019
2019-08-05 2019-06-30 13F BIO TECHNE CORP COM Stock 09073M104 124 0 0.00 26 4.00 0.0025
2019-05-01 2019-03-31 13F BIO TECHNE CORP COM Stock 09073M104 124 0 0.00 25 47.06 0.0028
2019-02-05 2018-12-31 13F BIO TECHNE CORP COM Stock 09073M104 124 -33 -21.02 17 -46.87 0.0024
2018-11-01 2018-09-30 13F BIO TECHNE CORP COM Stock 09073M104 157 -23 -12.78 32 23.08 0.0040
2018-07-30 2018-06-30 13F BIO TECHNE CORP COM Stock 09073M104 180 18 11.11 26 8.33 0.0037
2018-05-08 2018-03-31 13F BIO TECHNE CORP COM Stock 09073M104 162 0 0.00 24 14.29 0.0037
2018-02-13 2017-12-31 13F BIO TECHNE CORP COM Stock 09073M104 162 0 0.00 21 5.00 0.0034
2017-11-15 2017-09-30 13F/A-1 BIO TECHNE CORP COM Stock 09073M104 162 80 97.56 20 100.00 0.0034
2017-08-07 2017-06-30 13F BIO TECHNE CORP COM Stock 09073M104 82 0 0.00 10 11.11 0.0019
2017-05-12 2017-03-31 13F/A-1 BIO TECHNE CORP COM Stock 09073M104 82 -39 -32.23 9 -25.00 0.0018
2017-05-12 2017-03-31 13F BIO TECHNE CORP COM Stock 09073M104 82 9
2017-02-14 2016-12-31 13F BIO TECHNE CORP COM Stock 09073M104 121 121 12 0.0028
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F BIO-TECHNE CORP COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F BIO-TECHNE CORP COM Stock Call 611 275 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.